Johnson & Johnson has appointed Darren Snellgrove as Vice President of Investor Relations, effective May 1, 2025. He succeeds Jessica Moore, who will become Group Chief Financial Officer for Johnson & Johnson Innovative Medicine. Both will continue reporting to Chief Financial Officer Joseph Wolk. Snellgrove, who has been with the company since 1999, brings extensive financial leadership experience across Innovative Medicine, MedTech, R&D, and Business Development. Moore, who led Investor Relations since 2021, will now oversee financial strategy for Innovative Medicine. The appointments reflect Johnson & Johnson’s commitment to leadership development and long-term strategy.